巨子生物(02367.HK)1月13日耗资1433.8万港元回购40万股 巨子生物(02367.HK)1月12日耗资1400万港元 回购40万股 相关事件 格隆汇1月13日丨巨子生物(02367.HK)公告，1月13日耗资1433.8万港元回购40万股，每股回购价35.64- 36.2港元。 ...

巨子生物(02367)发布公告，于2026年1月13日斥资1433.78万港元回购40万股。 ...

智通财经APP讯，巨子生物(02367)发布公告，于2026年1月13日斥资1433.78万港元回购40万股。 ...

第 1 頁 共 8 頁 v 1.3.0 | 1). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 35.941 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年12月9日 | | | | | | 2). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 35.956 | | | 變動日期 | 2025年12月10日 | | | | | | 3). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 34.7189 | | | 變動日期 | 2025年12月11日 | | | | | | 4). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 35.0909 | | | 變動日期 | 2025年12月12日 | | | | | | 5). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 34.7931 | | | 變動日期 ...

Group 1 - The article reports on share buybacks conducted by various companies on January 12, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.024 million shares [1][2] - Other notable companies involved in the buyback include Geely Automobile (00175) with 9.007 million shares repurchased for 151 million yuan, and Sunny Optical Technology (02382) with 1.24 million shares for 79.34 million yuan [1][2] - The total number of shares repurchased by Tencent represents 1.188% of its total share capital, while Geely's buyback accounts for 0.438% of its total share capital [2] Group 2 - The buyback activities reflect a trend among companies to return capital to shareholders, with some companies like Antong Oilfield Services (03337) and Weigao Group (01066) showing significant percentages of their total share capital being repurchased, at 2.460% and 6.459% respectively [2][3] - Companies such as Vitasoy International (00345) and Keep (03650) also participated in the buyback, with their repurchase amounts being 432,600 yuan and 28,900 yuan respectively, indicating a diverse range of companies engaging in this practice [3] - The data suggests a strategic move by these companies to enhance shareholder value and potentially stabilize their stock prices amid market fluctuations [1][2]

巨子生物(02367)发布公告，于2026年1月12日，该公司斥资1400.29万港元回购40万股股份，每股回购价 格为34.5-35.5港元。 ...

智通财经APP讯，巨子生物(02367)发布公告，于2026年1月12日，该公司斥资1400.29万港元回购40万股 股份，每股回购价格为34.5-35.5港元。 ...

格隆汇1月12日丨巨子生物(02367.HK)公告，1月12日耗资1400万港元回购40万股，每股回购价34.5-35.5 港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 巨子生物控股有限公司 呈交日期： 2026年1月12日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存 ...

Core Insights - The beauty industry is undergoing a significant transformation as consumers prioritize product ingredients and efficacy over marketing narratives and brand stories [1][2] - The competition among companies is shifting from traditional marketing to a focus on scientific validation and technical authority, particularly regarding core ingredients [1][3] Group 1: Industry Dynamics - The battle for defining the "ingredient king" is exemplified by the prolonged conflict between Huaxi Biological and Juzhi Biological over recombinant collagen, highlighting the industry's shift towards scientific discourse [1][2] - Companies are increasingly engaged in disputes over intellectual property and scientific narratives, as seen in the conflict between medical company Aierfu and skincare brand Zhanmeiya, which revolves around the storytelling of scientific advancements [3] Group 2: Market Competition - The competition for established, cash-generating scientific products is illustrated by the dispute between Shuiyang Co. and Ruoyu Chen over the agency rights for the Spanish brand "Mestique," which has shown remarkable growth in the Chinese market [5][6] - The financial performance of companies varies significantly, with some experiencing revenue growth alongside increased R&D spending, while others face declining revenues despite high R&D investments [6][7] Group 3: Consumer Behavior - A significant shift in consumer preferences is noted, with 58.8% of consumers prioritizing product ingredients in their purchasing decisions, indicating a growing demand for transparency and efficacy [15][21] - The rise of the "ingredient party" has led to increased scrutiny of product claims, pushing companies to provide credible testing reports and validate their ingredients [15][21] Group 4: Future Trends - The beauty industry's future is marked by a "scientific arms race," with brands striving to establish their authority in scientific research and ingredient validation [8][16] - Companies are exploring unique natural ingredients and integrating skincare with makeup, reflecting a trend towards holistic beauty solutions [20][21]